Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on August 15, 2025

Nanobles Corporation Contracts Akoode Tech to Build Plant Chat® Open AI Website

Nanobles Corporation Contracts Akoode Tech to Build Plant Chat® Open AI Website

Nanobles announces contract on Plant Chat®, an AI-powered platform for plant enthusiasts, growers, gardeners, plant medicine users, consumers, and researchers SANTA BARBARA, CA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- Nanobles Corporation …

Prefer Launches Soluble Coffee and Cocoa Powders, Raises Oversubscribed US$4.2M Pre-A to Fuel International Expansion

Prefer Launches Soluble Coffee and Cocoa Powders, Raises Oversubscribed US$4.2M Pre-A to Fuel International Expansion

Funding round co-led by At One Ventures and Chancery Hill Capital, with continued participation from Forge Ventures. SINGAPORE, SINGAPORE, SINGAPORE, August 15, 2025 /⁨EINPresswire.com⁩/ -- Prefer Launches Soluble Coffee and Cocoa Powders for Food …

Long-Standing Navy Program Accelerates Drone, AI, and Technology Development Under Field Conditions

Long-Standing Navy Program Accelerates Drone, AI, and Technology Development Under Field Conditions

The Naval Postgraduate Schools' (NPS) Joint Field Experimentation Events (JIFX) successfully expedite mission critical defense capabilities into the Navy, DOD. MONTEREY, CA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- The roar from cutting-edge …

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued Press Release with same title DENVER …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions